PHIO PHARMACEUTICALS CORP. Payments for (Proceeds from) Other Investing Activities
PHIO PHARMACEUTICALS CORP. (PHIO) reported Payments for (Proceeds from) Other Investing Activities of $18.00 thousand for the 12-month period ending 2013-12-31, per its 10-K filed 2015-03-30.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsForProceedsFromOtherInvestingActivities · last filed 2015-03-30
- PHIO PHARMACEUTICALS CORP. payments for (proceeds from) other investing activities for the quarter ending 2012-12-31 was $0.00.
- PHIO PHARMACEUTICALS CORP. payments for (proceeds from) other investing activities for fiscal 2013 was $18.00K, a 800.00% increase from fiscal 2012.
- PHIO PHARMACEUTICALS CORP. payments for (proceeds from) other investing activities for fiscal 2012 was $2.00K.
| Period end | Payments for (Proceeds from) Other Investing Activities 3 month | Payments for (Proceeds from) Other Investing Activities 9 month | Payments for (Proceeds from) Other Investing Activities 12 month | Payments for (Proceeds from) Other Investing Activities 117 month |
|---|---|---|---|---|
| 2013-12-31 | $18.00K 10-K · filed 2015-03-30 | |||
| 2012-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-28 | $2.00K 10-K · filed 2014-03-28 | ||
| 2012-09-30 | $2.00K 10-Q · filed 2013-11-14 | $47.00K 10-Q · filed 2012-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |